Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoffer Brynte

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Alcoholism, Clinical and Experimental Research|November 22, 2018
Working Memory Training in Alcohol Use Disorder: A Randomized Controlled TrialLotfi Khemiri, Christoffer Brynte, Angela Stunkel, et al.
The International Journal on Drug Policy|April 30, 2026
Needle and syringe coverage per injection and factors associated with needle sharing among clients of the Stockholm Needle and Syringe Program, 2013-2023Maxim Kan, Elin Holmén, Christoffer Brynte, et al.
BMC Psychiatry|July 24, 2023
Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorderChristoffer Brynte, Lotfi Khemiri, Hannes Stenström, et al.
BMC Psychiatry|September 19, 2021
Self-rated impulsivity in healthy individuals, substance use disorder and ADHD: psychometric properties of the Swedish Barratt impulsiveness scaleLotfi Khemiri, Christoffer Brynte, Maija Konstenius, et al.
European Addiction Research|November 29, 2023
The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject StudyChristoffer Brynte, Maija Konstenius, Lotfi Khemiri, et al.
European Addiction Research|June 30, 2020
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future ActivitiesGeurt Van de Glind, Christoffer Brynte, Arvid Skutle, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 2026
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Maija Konstenius, et al.
The International Journal of Social Psychiatry|June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 28, 2026
Polygenic risk scores reveal genetic underpinnings of comorbidity betweensubstance use disorders and ADHDLisa I Horstman, Dora Koller, Judit Cabana-Domínguez, et al.
The Journal of Clinical Psychiatry|December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Alcoholism, Clinical and Experimental Research|November 22, 2018
Working Memory Training in Alcohol Use Disorder: A Randomized Controlled TrialLotfi Khemiri, Christoffer Brynte, Angela Stunkel, et al.
The International Journal on Drug Policy|April 30, 2026
Needle and syringe coverage per injection and factors associated with needle sharing among clients of the Stockholm Needle and Syringe Program, 2013-2023Maxim Kan, Elin Holmén, Christoffer Brynte, et al.
BMC Psychiatry|July 24, 2023
Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorderChristoffer Brynte, Lotfi Khemiri, Hannes Stenström, et al.
BMC Psychiatry|September 19, 2021
Self-rated impulsivity in healthy individuals, substance use disorder and ADHD: psychometric properties of the Swedish Barratt impulsiveness scaleLotfi Khemiri, Christoffer Brynte, Maija Konstenius, et al.
European Addiction Research|November 29, 2023
The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject StudyChristoffer Brynte, Maija Konstenius, Lotfi Khemiri, et al.
European Addiction Research|June 30, 2020
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future ActivitiesGeurt Van de Glind, Christoffer Brynte, Arvid Skutle, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 2026
Predictors of treatment success in patients with substance use disorder (SUD) and co-morbid attention deficit/hyperactivity disorder (ADHD): Results from the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Maija Konstenius, et al.
The International Journal of Social Psychiatry|June 13, 2025
Religiousness and self-control in patients with substance use disorder (SUD) and comorbid attention deficit/hyperactivity disorder (ADHD)Alex Ha Begeman, Arnt Schellekens, Wim van den Brink, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 28, 2026
Polygenic risk scores reveal genetic underpinnings of comorbidity betweensubstance use disorders and ADHDLisa I Horstman, Dora Koller, Judit Cabana-Domínguez, et al.
The Journal of Clinical Psychiatry|December 26, 2024
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS)Christoffer Brynte, Arnt Schellekens, Csaba Barta, et al.
Pageof 2